ESC 365 - Potential use of PCSK9 inhibitors in secondary prevention for patients with treated acute coronary syndrome. A study from a large UK university teaching hospital

EAPC Premium Access

Potential use of PCSK9 inhibitors in secondary prevention for patients with treated acute coronary syndrome. A study from a large UK university teaching hospital

Session: Poster Session I - Thursday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 2

Topic: Lipids

Speaker: Doctor A. Elamin (Liverpool, GB)

Event: EuroPrevent 2017

Congress Presentation

Add to my library

About the speaker

Doctor Ahmed Farouk Mohamed Elamin

Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)

0 follower

8 more presentations in this session

Diabetes/ Lipids/Obesity/Nutrition_Part 2 - Poster discussant: .

Familial heterozygous dyslipidemia evaluation in lipid treated populations : FHELP

Speaker: Doctor J. Daigle (Halifax, CA)

Age-related differences in the lipid profile in patients admitted to a cardiac rehabilitation program

Speaker: Doctor A. Chauca Tapia (Girona, ES)

Statin-treated patients: are the lipid goals reached?

Speaker: Doctor K. Mzoughi (Bizerta, TN)

Lipid profile comparisons in women with acute myocardial infarction of different age

Speaker: Associate Professor D. Platonov (Tver, RU)

Access the full session

Poster Session I - Thursday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 2

Speakers: Doctor A. Elamin, Doctor J. Daigle, Doctor A. Chauca Tapia, Doctor K. Mzoughi, Associate Professor D. Platonov

About the event

EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources